Scotts Miracle-Gro has seen a sharp share-price swing over the past few years, and the latest bounce leaves a clear question for you as an investor. Is the current US$59.15 stock price in line with what the company's cash flows can reasonably support over time, or has sentiment moved ahead of the underlying economics?
-
The share price is down 51.3% over 5 years, which puts the focus squarely on whether the cash generation story has changed enough to justify where the stock now trades.
-
UBS recently upgraded Scotts Miracle-Gro, arguing that expectations for future revenue expansion and productivity may support stronger cash flow than the market had been pricing in.
-
What if you looked at Scotts Miracle-Gro through its earnings instead? See why Scotts Miracle-Gro's 22.2x P/E tells a different valuation story .
The stock's next move may depend on whether Scotts Miracle-Gro's current valuation is fully supported by the cash flows implied in a Discounted Cash Flow (DCF) view.
If you are weighing whether Scotts Miracle-Gro's cash flows justify today's price, it can help to compare that setup with a wider list of 30 high quality undervalued stocks .
Does Scotts Miracle-Gro Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) model here is built on Scotts Miracle-Gro's ability to keep generating cash for shareholders. Latest twelve-month free cash flow sits at about $280.3 million, and the forecast path only edges this higher over time, which implies a recovering but not explosive profile for the business. Those are measured assumptions, closer to a steady franchise than a high-growth story.
On that foundation, the DCF points to an estimated intrinsic value that is substantially above the current US$59.15 share price. UBS's recent upgrade, which leans on modest revenue growth and productivity gains, broadly lines up with a valuation picture that already assumes only gradual improvement in free cash flow. Despite the positive broker call adding attention after the pullback, the market is still pricing Scotts Miracle-Gro below what this cash flow model suggests its operations can reasonably support over time. Find out what Scotts Miracle-Gro could be worth using our Discounted Cash Flow (DCF) estimate .
The Scotts Miracle-Gro Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the cash flow puzzle for Scotts Miracle-Gro leaves off, spelling out which growth paths, margin levels and earnings profiles would need to play out for the stock to be worth materially more or less than today's price on the Community page. Each one treats fair value as a hypothesis about the business that you can watch over time, rather than a single frozen number.
Community views on Scotts Miracle-Gro split between a margin recovery story and a concern that the stock already bakes in too much optimism.
Bull case: 26% undervalued
"Ongoing cost savings and automation in the supply chain, with over US$100 million in cost reductions already captured toward a US$180 million target..."
Discover why this Narrative puts Scotts Miracle-Gro at 26% undervalued .
Bear case: 36% overvalued
"Pandemic-era demand spikes, followed by normalization and channel inventory corrections, weighed heavily on results and investor sentiment..."
Explore why this Narrative puts Scotts Miracle-Gro at 36% overvalued .
Before acting on Scotts Miracle-Gro's valuation, weigh what our risk checks are flagging
Valuation only tells part of the story for Scotts Miracle-Gro, because independent checks have highlighted potential pressure points in the background that investors often overlook until they matter most. Take a closer look at 3 warning signs (1 major) before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SMG .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
